Starsource Multitrade Limited has announced that its register of members and share transfer books will remain closed from Tuesday, September 22, 2026, to Saturday, September 27, 2026. This closure is for the purpose of its 84th Annual General Meeting, scheduled for Monday, September 28, 2026.

The company, formerly known as Chemo Pharma Laboratories Limited, confirmed that the record date for e-voting is set for Monday, September 21, 2026. Shareholders holding equity shares of face value ₹10 each on this record date will be eligible to vote at the AGM.

Meeting Details

The 84th AGM will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM) in compliance with SEBI and MCA regulations. The meeting is scheduled for 4:00 pm on September 28, 2026.

The Board of Directors approved these details during a meeting held on Tuesday, September 1, 2026, at the company’s registered office in Kalyan. The board also appointed a scrutinizer for the meeting and fixed the book closure dates.

Agenda and Re-appointment

The primary agenda for the meeting includes considering and adopting the Audited Financial Statements for the Financial Year ended March 31, 2026, along with the reports of the Board of Directors and Auditors.

Additionally, shareholders will vote on the re-appointment of Mr. Ruchit Mehta (DIN: 08810586), the Managing Director & Chief Executive Officer, who retires by rotation and is offering himself for re-appointment.

Voting Process

Pursuant to Section 108 of the Companies Act, 2013, the company has engaged Central Depository Services (India) Limited (CDSL) to facilitate remote e-voting. The remote e-voting period commences on Thursday, September 25, 2026, at 9:00 am and ends on Saturday, September 27, 2026, at 5:00 pm.

Members can join the AGM in VC/OAVM mode 15 minutes before the scheduled time. The facility is available to at least 1,000 members on a first-come, first-served basis, excluding large shareholders (holding 2% or more), promoters, institutional investors, and directors. Physical attendance and proxy appointments are not permitted for this virtual meeting.

Compliance and Filings

Starsource Multitrade filed the intimation regarding the book closure with the Bombay Stock Exchange on September 1, 2026. This filing was made pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act, 2013.

Previously, the company published newspaper advertisements in Business Standard and Mumbai Lakshdeep on August 31, 2026, to inform equity shareholders about the virtual meeting format. The initial intimation for the AGM was filed with BSE on August 27, 2026.

Starsource Multitrade reported a net loss of ₹118.55 crore for the financial year ended March 31, 2026, marking a sharp reversal from the ₹34.22 lakh profit recorded in FY25. The company’s revenue from operations stood at ₹52.57 lakh, while other income dropped significantly to ₹23.89 lakh from ₹61.98 lakh in the prior year.

The financial deterioration was primarily driven by substantial losses on investments booked under indirect expenses, which accounted for the vast majority of the total expenditure. Total expenses surged to ₹124.04 crore from ₹12.18 lakh in FY25, with 'Other Expenses' alone reaching ₹119.38 crore. This includes a specific loss on the sale of investments amounting to ₹118.72 crore.

What the Numbers Show

The divergence between the company's operating activities and its investment portfolio is stark. While operational revenue was minimal at ₹52.57 lakh, the balance sheet reflects a massive depletion of liquid assets. Cash and cash equivalents plummeted from ₹106.23 crore to just ₹1.22 lakh during the year. This suggests that the company liquidated significant portions of its investment portfolio, likely triggering the large fair value losses recorded in the statement of profit and loss.

Balance Sheet Signals

Total assets contracted sharply from ₹133.50 crore to ₹18.12 crore. Non-current financial assets, which included inter-corporate deposits of ₹25.08 crore in FY25, were completely derecognized in FY26. Conversely, current assets saw the emergence of trade receivables worth ₹48.84 lakh and loans and deposits of ₹130.41 lakh, indicating a shift in asset composition towards shorter-term instruments and working capital requirements.

Corporate Developments

The fiscal year witnessed a complete change in management following a stake sale by promoters to Atibha Agriseeds Private Limited. The erstwhile Board of Directors resigned effective April 16, 2025. New leadership includes Ruchit Mehta as Managing Director and CEO, and Utsav Trivedi as Executive Director and CFO. The company also announced no dividend for FY26 to conserve funds amidst the losses.